Breaking News Instant updates and real-time market news.

CNC

Centene

$98.16

7.28 (8.01%)

, AET

Aetna

$162.30

-0.53 (-0.33%)

16:18
09/13/17
09/13
16:18
09/13/17
16:18

On The Fly: Top stock stories for Wednesday

Stocks opened close to fair value and remained little changed throughout the day. The averages moved in a narrow range as they consolidated following their record close last night. Oil prices rallied over 2% after recently struggling following the two hurricanes in the southern part of the country. The weekly Department of Energy inventory report showed a larger than expected build in supply, but it was not enough to unnerve the bulls, who pushed the price of crude above $49 a barrel. ECONOMIC EVENTS: In the U.S., the producer-price index rose 0.2% in August with the core rate up 0.1%, both of which were a bit below expectations. In Asia, Japan's PPI grew 2.9% year-over-year in August, representing its highest growth level since 2008. COMPANY NEWS: Shares of Centene (CNC) advanced 8% after the health insurer announced last night a "highly accretive" acquisition of Fidelis Care for $3.75B. As other healthcare insurers like Aetna (AET), Anthem (ANTM) and UnitedHealth (UNH) step back from the Affordable Care Act's challenged insurance exchanges, Centene continues to execute on the ACA's public insurance exchange. Following the Fidelis deal, Centene will now have "leadership" position in the country's four largest managed care states by membership - California, Florida, New York and Texas. MAJOR MOVERS: Among the notable gainers was Nordstrom (JWN), which rose 6% after CNBC reported that the family that controls the department store chain is close to a deal to choose private equity firm Leonard Green & Partners to help fund a "go private" deal. Also higher was Target (TGT), whose shares climbed nearly 3% after the company announced that it will hire significantly more seasonal workers this holiday season than last year. Among the noteworthy losers was Western Digital (WDC), which dropped over 3% after joint-venture partner Toshiba (TOSYY) said it has entered into a memorandum of understanding with a consortium lead by Bain Capital with the intent to negotiate a definitive agreement for the sale of Toshiba Memory Corporation by the end of this month. Also lower was USG (USG), which fell about 4.5% after chief executive officer Jennifer Scanlon said during an industry presentation that the consensus view for the company's Q3 earnings may be optimistic due to headwinds associated with the aftermath of Hurricane Harvey. Additionally, iRobot (IRBT) slid over 15% after Shark officially announced its entrance into the robotic vacuum category with its ION device. INDEXES: The Dow rose 39.32, or 0.18%, to 22,158.18, the Nasdaq gained 5.91, or 0.09%, to 6,460.19, and the S&P 500 added 1.89, or 0.08%, to 2,498.37.

CNC

Centene

$98.16

7.28 (8.01%)

AET

Aetna

$162.30

-0.53 (-0.33%)

ANTM

Anthem

$189.72

0.48 (0.25%)

UNH

UnitedHealth

$198.33

0.86 (0.44%)

JWN

Nordstrom

$47.74

2.69 (5.97%)

TGT

Target

$59.52

1.63 (2.82%)

WDC

Western Digital

$85.74

-3.04 (-3.42%)

IRBT

iRobot

$85.08

-15.79 (-15.65%)

TOSYY

Toshiba, also use TOSBF

$18.03

0.02 (0.11%)

TOSBF

Toshiba, also use TOSYY

$3.02

0.016 (0.53%)

USG

USG

$30.50

-1.48 (-4.63%)

  • 13

    Sep

  • 13

    Sep

  • 13

    Sep

  • 14

    Sep

  • 14

    Sep

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 24

    Oct

CNC Centene
$98.16

7.28 (8.01%)

09/13/17
LEER
09/13/17
NO CHANGE
Target $90
LEER
Market Perform
Centene price target raised to $90 from $78 at Leerink
Leerink analyst Ana Gupte raised her price target for Centene to $90 from $78 as she is positive on it after the announcement of the Fidelis AMC acquisition. The analyst reiterates a Market Perform rating on the shares.
09/13/17
CANT
09/13/17
NO CHANGE
Target $107
CANT
Overweight
Centene price target raised to $107 from $100 at Cantor
Cantor Fitzgerald analyst Steven Halper raised his price target for Centene shares to $107 following the company's acquisition of Fidelis Care. The analyst views the acquisition positively, both from a strategic and financial perspective. He keeps an Overweight rating on Centene.
09/13/17
MSCO
09/13/17
NO CHANGE
Target $94
MSCO
Overweight
Deal for Fidelis 'in Centene's wheelhouse,' says Morgan Stanley
Morgan Stanley analyst Zack Sopcak sees Fidelis Care as a strong fit, both culturally and in terms of business mix, for Centene, calling the acquisition a deal "in Centene's wheelhouse." The analyst, who views the downside to the deal as limited given what he sees as modest synergy targets, keeps an Overweight rating and $94 price target on Centene shares.
07/26/17
PIPR
07/26/17
NO CHANGE
Target $105
PIPR
Overweight
Piper says double down on Centene, ups target to $105
Piper Jaffray analyst Sarah James attributes yesterday's post-earnings pullback in shares of Centene to the macro backdrop and the company's spending bump that she believes fuels the bear concern that constant spending for growth pressures margins. The analyst "strongly" disagrees and believe this is when investors should double down on Centene shares. The company will see the greatest multiple expansion in the group and has the highest potential for earnings upside, James tells investors in a research note. She raised her price target for the shares to $105 from $85 and keeps an Overweight rating on the name.
AET Aetna
$162.30

-0.53 (-0.33%)

09/12/17
ARGS
09/12/17
NO CHANGE
ARGS
Aetna price target raised to $185 from $165 at Argus
Argus analyst David Toung believes that Aetna reported "strong" Q2 results. The analyst remains upbeat on the company's 2H17 outlook and keeps a Buy rating on the shares.
07/14/17
PIPR
07/14/17
NO CHANGE
Target $18
PIPR
Overweight
Piper views updated Aetna policy as disappointing for Natera
Piper Jaffray analyst William Quirk views Aetna's (AET) updated non-invasive prenatal testing medical policy, where it decided to continue covering the test only in high risk, as "disappointing." Upside for Natera (NTRA) in the second half of 2017 now falls on Medicaid and microdeletion reimbursement progress, and less so commercial payers flipping to cover average risk, Quick tells investors in a research note. He keeps an Overweight rating on Natera shares with an $18 price target.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $165
FBCO
Outperform
Aetna price target raised to $165 from $160 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Aetna to $165 from $160 ahead of Q2 results. He reiterates an Outperform rating on the shares.
06/28/17
06/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altaba (AABA) initiated with an Overweight at JPMorgan. 2. Aetna (AET) and Humana (HUM) were initiated with a Buy at Citi. The firm also added Aetna to its Focus List. 3. CVS Health (CVS) and Walgreens Boots Alliance (WBA) were initiated with a Hold at Needham. 4. Oaktree Capital (OAK) initiated with a Hold at Jefferies. 5. General Motors (GM) resumed with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ANTM Anthem
$189.72

0.48 (0.25%)

07/12/17
FBCO
07/12/17
INITIATION
Target $195
FBCO
Neutral
Anthem initiated with a Neutral at Credit Suisse
Credit Suisse analyst Scott Fidel started Anthem with a Neutral rating and $195 price target. The company has produced slower earnings growth over the past decade relative to Managed Care peers and its returns on capital are also "sub-par relative to comps," the analyst contends. He believes Anthem is "entering a new chapter" following the failed Cigna (CI) acquisition and "uncertain future" of the Affordable Care Act's exchanges and Medicaid expansion.
06/28/17
SBSH
06/28/17
NO CHANGE
Target $205
SBSH
Buy
Anthem removed from Focus List at Citi
Citi analyst Ralph Giacobbe removed Anthem (ANTM) from his firm's Focus List but keeps a Buy rating on the shares with a $205 price target. The analyst believes some of the upside catalysts have played out. He also added Aetna (AET) to the Focus List.
06/23/17
LEER
06/23/17
NO CHANGE
LEER
Outperform
Draft version of Senate healthcare bill better than expected, says Leerink
Leerink analyst Ana Gupte said she views the draft version of the Senate healthcare bill as better than expected, stating that stabilization of the Exchanges and risk stabilization is a direct positive for health insurers and indirect positive for facility operators. The Senate bill maintains the House bill's plan to repeal all "ObamaCare" industry fees and taxes, which is a positive for Managed Care and Medical Technology players, Gupte adds. She keeps Outperform ratings on Anthem (ANTM), UnitedHealth (UNH), Cigna (CI), Humana (HUM), WellCare (WCG), Molina Healthcare (MOH) and acute care hospital operators HCA Holdings (HCA), Tenet (THC) and LifePoint (LPNT).
06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
UNH UnitedHealth
$198.33

0.86 (0.44%)

08/30/17
ADAM
08/30/17
DOWNGRADE
Target $54
ADAM
Hold
The Advisory Board downgraded to Hold from Buy at Canaccord
Canaccord analyst Richard Close downgraded The Advisory Board (ABCO) to Hold from Buy based on the announced transaction to split the company by selling the Healthcare business to UnitedHealth's (UNH) Optum unit and the Education Business to Vista Equity Partners. Close lowered his price target to $54.29 on Advisory Board shares.
08/11/17
COWN
08/11/17
NO CHANGE
Target $220
COWN
Outperform
UnitedHealth price target raised to $220 from $175 at Cowen
Cowen analyst Christine Arnold raised her price target on UnitedHealth to $220 from $175. The analyst believes the company can achieve its long-term growth targets in 2018, citing Medicare Advantage enrollment growth, operating efficiencies, commercial market penetration, and OptumRx and OptumInsight earnings gains. Arnold reiterated her Outperform rating on UnitedHealth shares.
08/16/17
PIPR
08/16/17
NO CHANGE
PIPR
Overweight
UnitedHealth made 'solid choice' in new CEO, says Piper Jaffray
Piper Jaffray analyst Sarah James views UnitedHealth's promotion of David Wichmann as a "solid choice and not a surprise." The analyst expects business as usual for the company as it continues to push into technology including artificial intelligence. She has an Overweight rating on the shares.
08/29/17
PIPR
08/29/17
NO CHANGE
Target $54.29
PIPR
Neutral
Piper says Advisory Board deal should be marginally accretive to UnitedHealth
Piper Jaffray analyst Sean Wieland said Advisory Board's (ABCO) deal to merge its healthcare business with United Healthcare's (UNH) OptumInsights should be marginally accretive to UnitedHealth and add to his confidence in his FY18 OptumInsights growth estimates. He keeps a Neutral rating on Advisory Board shares and raised his price target on the stock to $54.29 from $51 to reflect the combined estimated amount being paid to shareholders by Optum and Vista Equity, the buyers of Advisory's education business.
JWN Nordstrom
$47.74

2.69 (5.97%)

06/21/17
GDHS
06/21/17
NO CHANGE
GDHS
Nike-Amazon pact yet another department store headwind, says Gordon Haskett
Gordon Haskett analyst noted the reports of Nike (NKE) nearing a deal to sell directly on Amazon (AMZN), which he said wouldn't impact trends overnight but would represent another headwind for department stores, particularly J.C. Penney (JCP) and Kohl's (KSS), where the brand has a larger penetration than at Macy's (M) and Nordstrom (JWN). He keeps an Accumulate rating on Nordstrom, a Hold rating on Macy's and Reduce rating on both J.C. Penney and Kohl's.
07/14/17
JPMS
07/14/17
NO CHANGE
JPMS
Underweight
JPMorgan keeps Underweight on Nordstrom after management meetings
JPMorgan analyst Matthew Boss keeps an Underweight rating on Nordstrom (JWN) after meeting management at the company's headquarters. Management would not comment on their evaluation of strategic alternatives and the meeting was reshuffled to exclude members of the Nordstrom family while incoming CFO Anne Bramman attended but did not actively participate, Boss tells investors in a research note. The analyst views the company's EBITDA roadmap as "increasingly uncertain" with a greater emphasis on fashion to differentiate mix versus Amazon.com (AMZN) and rising costs of customer acquisition. He believes the retailer's fundamental multi-year risk profile is elevated.
09/13/17
GDHS
09/13/17
DOWNGRADE
GDHS
Hold
Nordstrom downgraded to Hold from Accumulate at Gordon Haskett
09/13/17
09/13/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. ON Semiconductor (ON) downgraded to Neutral from Buy at Goldman Sachs with analyst Mark Delaney citing the stock's relative outperformance and lack of catalysts over the next year. 2. Nordstrom (JWN) downgraded to Hold from Accumulate at Gordon Haskett. 3. Mallinckrodt (MNK) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying Mallinckrodt consists of a gradually declining generics portfolio, and a "basket" of branded assets that face some degree of competition and downside risks. 4. Whiting Petroleum (WLL) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Drew Venker citing weak risk-reward relative to peers. 5. GasLog (GLOG) downgraded to Hold from Buy at DNB Markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TGT Target
$59.52

1.63 (2.82%)

08/17/17
BWSF
08/17/17
NO CHANGE
Target $14
BWSF
Strong Buy
Barnes & Noble Education 'a weapon' as retailers take on Amazon, says BWS
Barnes & Noble Education (BNED) has become "a weapon" in the fight between traditional brick and mortar retailers and Amazon (AMZN), BWS Financial analyst Vahid Khorsand tells investors in an intraday research note. Target's (TGT) partnership with Barnes & Noble Education to deliver college essentials directly to students "has so far gone unappreciated by the market," the analyst contends. He believes Barnes & Noble Education's earnings report on August 30 could serve as a catalyst for the stock on "multiple fronts." Khorsand has a Buy rating on the name with a $14 price target.
08/22/17
JEFF
08/22/17
NO CHANGE
JEFF
Weak spending from Hispanic consumers likely temporary, says Jefferies
A team of Jefferies analysts note that several consumer companies have flagged weakness from Hispanic consumers during this earnings season, which they attribute to likely being linked to uncertainty around immigration policy more than a result of a deteriorating economic backdrop. Companies that have been hurt may be due for a rebound as this is assumed to be a short term phenomenon and some have already noted improvement, the team tells investors. Some of the companies that recently have specifically flagged weakness in Hispanic spending include Foot Locker (FL), Murphy USA (MUSA), O'Reilly Automotive (ORLY), Target (TGT), Valvoline (VVV) and Wingstop (WING), the firm noted.
08/25/17
08/25/17
NO CHANGE

Price cuts not a 'silver bullet' for Amazon to disrupt grocery, says Citi
Citi analyst Alvin Concepcion noted that a number of food retail stocks sold off yesterday after Amazon (AMZN) announced price reductions on certain top selling items at Whole Foods (WFM) stores beginning on Monday when their deal closes, but he contends "price cuts alone are not a silver bullet to becoming a disruptive threat" in an industry that already has many discount operators. He adds that he would be wary of a more significant negative overreaction to news around Amazon's price plans at Whole Foods at this time. Some of the food retailing stocks that declined yesterday included Wal-Mart (WMT), Target (TGT), Kroger (KR), Sprouts Farmers Market (SFM), Costco (COST) and Supervalu (SVU).
09/11/17
BERN
09/11/17
NO CHANGE
Target $68
BERN
Outperform
Target everyday low pricing move not surprising, says Bernstein
Bernstein analyst Brandon Fletcher notes that Target announced that it is lowering prices on thousands of consumables items, and its stock is "unsurprisingly" down on the news. It really should not be, Fletcher said, adding that Target had previously announced the move at a recent financial community meeting where management commented on its price investment strategy as, "We've got to make sure that we move from a promotional cadence back to our traditional everyday low price." The analyst reiterates an Outperform rating and $68 price target on the shares.
WDC Western Digital
$85.74

-3.04 (-3.42%)

09/13/17
LBOW
09/13/17
NO CHANGE
Target $120
LBOW
Buy
iPhone 64GB starting point a 'pleasant surprise' for NAND makers, says Longbow
Longbow analyst Joe Wittine said many had expected a 32GB starting point for the memory in the new iPhones, consistent with the 7/7+, calling the new 64GB starting point for the iPhone 8/8+ a "pleasant surprise" for companies in the NAND supply chain. Rising NAND consumption could help smooth the eventual downside of the cycle for Western Digital, helping it maintain greater than 40% gross margins for longer, added the analyst. Wittine keeps a Buy rating and $120 price target on Western Digital shares.
09/13/17
SBSH
09/13/17
NO CHANGE
Target $110
SBSH
Buy
Citi still sees Western Digital participating in Toshiba joint venture
Citi analyst Stanley Kovler says he continues to believe Western Digital (WDC) will be able to participate in the joint venture with Toshiba (TOSYY, TOSBF) and source NAND much like it has in the past, even after Toshiba signed a memorandum of understanding with the Bain Capital consortium for the sale of its memory business. If Western Digital takes a more commercial approach to resolution versus a legal route, the analyst sees a path to work with Bain and co-invest in Fab6. Kovler keeps a Buy rating on Western Digital with a $110 price target.
09/12/17
RBCM
09/12/17
NO CHANGE
RBCM
Western Digital likely to hold minority stake in Toshiba, says RBC Capital
After Japanese newspaper Nikkan reported that a consortium which includes Western Digital (WDC) would buy Toshiba's (TOSBF) memory assets, RBC Capital analyst Amit Daryanani says that Western Digital will likely hold a minority stake in the assets, given anti-trust concerns. The analyst estimates that a 12%-13% stake would boost Western Digital's EPS by 25c-30c in 2018. Daryanani believes that the deal will be positive for the company as it will enable it to secure NAND bit capacity, prevent Foxconn/SK Hynix from getting the asset, and could boost its profits. He keeps a $115 price target and an Outperform rating on the stock.
09/11/17
JEFF
09/11/17
DOWNGRADE
JEFF
Hold
Seagate downgraded to Hold from Buy at Jefferies
Jefferies analyst James Kisner downgraded Seagate Technology (STX) to Hold after his channel checks indicated the company may still be struggling with the ramp of its 10TB helium drives. The analyst is also hearing about about potential increased price competition in nearline. He cut his price target for Seagate shares to $29 from $40. Kisner maintains a Hold rating on Seagate peer Western Digital (WDC).
IRBT iRobot
$85.08

-15.79 (-15.65%)

07/03/17
DOTC
07/03/17
DOWNGRADE
DOTC
Neutral
iRobot downgraded to Neutral from Buy at Dougherty
Dougherty analyst Jon Fisher downgraded iRobot to Neutral.
07/03/17
07/03/17
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. GMS Inc. (GMS) upgraded to Buy from Neutral at Northcoast. 2. Telecom Argentina (TEO) upgraded to Buy from Neutral at BofA/Merrill with analyst Rodrigo Villanueva citing the company's merger agreement with Cablevision Holding S.A. 3. iRobot (IRBT) downgraded to Neutral from Buy at Dougherty. 4. AeroVironment (AVAV) downgraded to Neutral from Overweight at Piper Jaffray with analyst Troy saying given the "historical lumpiness" in sales for AeroVironment's commercial drone market and international opportunities, investors will be able to purchase shares at more attractive valuations in future quarters. He raised his price target for the shares to $35 from $30. 5. ShotSpotter (SSTI) initiated with an Outperform at Northland. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/26/17
PIPR
07/26/17
NO CHANGE
Target $92
PIPR
Neutral
iRobot price target raised to $92 from $68 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for iRobot to $92 saying the company reported "another impressive quarter with significant" revenue and earnings upside. The robotic vacuum cleaner market is "obviously inflecting" and iRobot's market share is "rapidly increasing," Jensen tells investors in a research note. The analyst remains upbeat about the company's market position but keeps a Neutral rating on the shares due to valuation.
09/13/17
JPMS
09/13/17
NO CHANGE
JPMS
Underweight
JPMorgan cautious on iRobot after Shark enters robotic vacuum space
Shark officially announced its entrance into the robotic vacuum category with features that appear to match the capabilities of iRobot's Roomba 600 and 800 series, but at a lower price, JPMorgan analyst Mark Strouse tells investors in a research note. Shark's ION robot will be available at an "impressive list" of U.S. retail distribution partners, the analyst adds. He sees the new product as adding to an increasingly competitive landscape and, at a minimum, weighing on investor sentiment for iRobot. Further, ION may present a risk to what the analyst sees as elevated investor expectations for iRobot. Strouse keeps an Underweight rating on iRobot shares. The stock in midday trading is down 11%, or $11.35, to $89.52.
TOSYY Toshiba, also use TOSBF
$18.03

0.02 (0.11%)

08/14/17
SBSH
08/14/17
UPGRADE
SBSH
Buy
Toshiba upgraded to Buy from Neutral at Citi
Citi analyst Kota Ezawa upgraded Toshiba to Buy saying the company's August 10 briefing indicated that there is reduced risk of additional WEC losses and the NAND business is generating "remarkably high profit." The probability of Toshiba rebuilding and remaining a going concern has increased significantly, the analyst tells investors in a research note. Ezawa now puts the possibility of Toshiba, delisting at less than 30%. The analyst has 430 yen price target for the shares.
06/27/17
BTIG
06/27/17
NO CHANGE
BTIG
Western Digital fundamentals still 'quite strong,' says BTIG
BTIG analyst Edward Parker says that Western Digital's (WDC) "strong preliminary results" indicate that its "fundamentals remain quite strong." The analyst says he doesn't believe that Toshiba (TOSBF, TOSYY) can sell its share in the chip joint venture while Western Digital is seeking injunctive relief. He adds that the intensity of the battle over the joint venture shows that there is widespread optimism about the memory sector. He keeps a $120 price target and a Buy rating on Western Digital.
08/23/17
COWN
08/23/17
NO CHANGE
Target $117
COWN
Outperform
Western Digital deal with Toshiba would eliminate overhang, says Cowen
Cowen analyst Karl Ackerman said a deal between Western Digital (WDC) and Toshiba (TOSBF) could be voted on by the end of August, which would remove an overhang on Western Digital shares. The analyst sees a deal being accretive through calendar year 2019 and also believes it would eliminate risks surrounding IP leakage and NAND technology leadership. Ackerman reiterated his Outperform rating and $117 price target on Western Digital shares.
TOSBF Toshiba, also use TOSYY
$3.02

0.016 (0.53%)

USG USG
$30.50

-1.48 (-4.63%)

06/15/17
CLVD
06/15/17
NO CHANGE
CLVD
Cleveland Research sees downside to USG quarter on softer demand, pricing
07/27/17
BOFA
07/27/17
DOWNGRADE
Target $31
BOFA
Neutral
USG downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst John Lovallo downgraded USG to Neutral and cut its price target to $31 from $38 citing the disappointing Q2 report. The analyst said wallboard utilization remains depressed and the ceilings business is also challenged due to low growth and incremental competition.
07/24/17
KING
07/24/17
DOWNGRADE
KING
Neutral
USG downgraded to Neutral from Buy at CL King
06/22/17
FBCO
06/22/17
INITIATION
Target $24
FBCO
Underperform
USG initiated with an Underperform at Credit Suisse
Credit Suisse analyst Susan Maklari initiated USG with an Underperform and a $24 price target based on expectations for continued relative weakness in wallboard, expected raw material inflation, an increasing competitive environment from low growth, and risks associated with the sale of L&W Supply.

TODAY'S FREE FLY STORIES

OHI

Omega Healthcare

$32.53

-0.12 (-0.37%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Hot Stocks
Omega Healthcare provides hurricane update »

Omega Healthcare provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

F

Ford

$11.72

0.09 (0.77%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Periodicals
Ford to slash production at five North American assembly plants, Reuters says »

Ford announced it intends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 26

    Oct

FDX

FedEx

$216.00

0.92 (0.43%)

18:26
09/19/17
09/19
18:26
09/19/17
18:26
Hot Stocks
FedEx says without cyberattack FY18 guidance would not have changed »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

EE

El Paso Electric

$54.85

0.05 (0.09%)

18:25
09/19/17
09/19
18:25
09/19/17
18:25
Hot Stocks
El Paso Electric announces City of El Paso approved settlement terms »

El Paso Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

18:17
09/19/17
09/19
18:17
09/19/17
18:17
Hot Stocks
Bed Bath & Beyond says biggest component in drop of FY17 EPS view is operations »

Company dropped its FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CPRT

Copart

$32.54

-0.32 (-0.97%)

18:11
09/19/17
09/19
18:11
09/19/17
18:11
Earnings
Copart reports Q4 EPS 30c, consensus 29c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

STLD

Steel Dynamics

$33.83

0.03 (0.09%)

18:04
09/19/17
09/19
18:04
09/19/17
18:04
Earnings
Steel Dynamics sees Q3 adjusted EPS 63c-67c, consensus 70c »

Steel Dynamics provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBKS

Xenith Bankshares

$29.96

0.42 (1.42%)

17:58
09/19/17
09/19
17:58
09/19/17
17:58
Hot Stocks
Treasury exits stake in Xenith Bankshares »

Xenith Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$62.93

0.23 (0.37%)

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Periodicals
Breaking Periodicals news story on Bristol-Myers »

Times:NHS will supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 26

    Oct

  • 09

    Nov

  • 05

    Mar

BBBY

Bed Bath & Beyond

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

DESP

Despegar.com

17:52
09/19/17
09/19
17:52
09/19/17
17:52
Syndicate
Despegar.com 12.7M share IPO priced at $26.00 »

The IPO priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WAC

Walter Investment

$0.65

0.186 (40.09%)

17:50
09/19/17
09/19
17:50
09/19/17
17:50
Hot Stocks
Walter Investment says Barclays to increase financing available »

On September 13, Walter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

17:49
09/19/17
09/19
17:49
09/19/17
17:49
Initiation
CymaBay initiated  »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

BBBY

Bed Bath & Beyond

17:46
09/19/17
09/19
17:46
09/19/17
17:46
Hot Stocks
Bed Bath & Beyond sees net drop in Bed Bath & Beyond stores in FY17 »

Says rate of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45
Initiation
Evolent Health initiated  »

Evolent Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPL

Buckeye Partners

$56.33

0.64 (1.15%)

17:44
09/19/17
09/19
17:44
09/19/17
17:44
Syndicate
Buckeye Partners announces $210M in limited partnership unit sales »

Buckeye Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$91.03

0.87 (0.96%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
Ralph Lauren initiated  »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

PVH

PVH Corp.

$127.47

-0.54 (-0.42%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
PVH Corp. initiated  »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

, ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Gemphire…

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

IOVA

Iovance Biotherapeutics

$8.55

0.3 (3.64%)

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

FDX

FedEx

$216.00

0.92 (0.43%)

ADBE

Adobe

$156.60

0.83 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

  • 25

    Sep

  • 22

    Oct

KORS

Michael Kors

$46.18

1.53 (3.43%)

17:42
09/19/17
09/19
17:42
09/19/17
17:42
Initiation
Michael Kors initiated  »

Michael Kors initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$39.23

-0.75 (-1.88%)

17:42
09/19/17
09/19
17:42
09/19/17
17:42
Initiation
L Brands initiated  »

L Brands initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$24.71

-0.02 (-0.08%)

17:41
09/19/17
09/19
17:41
09/19/17
17:41
Initiation
Hanesbrands initiated  »

Hanesbrands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

17:41
09/19/17
09/19
17:41
09/19/17
17:41
Recommendations
Bed Bath & Beyond analyst commentary  »

Bed Bath & Beyond Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GIII

G-III Apparel

$29.15

-0.26 (-0.88%)

17:41
09/19/17
09/19
17:41
09/19/17
17:41
Initiation
G-III Apparel initiated  »

G-III Apparel initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

-0.12 (-0.30%)

17:40
09/19/17
09/19
17:40
09/19/17
17:40
Initiation
Coach initiated  »

Coach initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.